These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heterologous and cross-species tropism of cancer-derived extracellular vesicles. Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511 [TBL] [Abstract][Full Text] [Related]
3. Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation. Garofalo M; Villa A; Brunialti E; Crescenti D; Dell'Omo G; Kuryk L; Vingiani A; Mazzaferro V; Ciana P Nanotheranostics; 2021; 5(1):1-7. PubMed ID: 33391971 [TBL] [Abstract][Full Text] [Related]
4. Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer. Li T; Zhou X; Wang J; Liu Z; Han S; Wan L; Sun X; Chen H Pharmacol Res; 2020 Jul; 157():104843. PubMed ID: 32360582 [TBL] [Abstract][Full Text] [Related]
6. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094 [TBL] [Abstract][Full Text] [Related]
7. Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesicles. Kakiuchi Y; Kuroda S; Kanaya N; Kumon K; Tsumura T; Hashimoto M; Yagi C; Sugimoto R; Hamada Y; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Urata Y; Fujiwara T Mol Ther; 2021 Oct; 29(10):2920-2930. PubMed ID: 34023506 [TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors. Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles: Natural liver-accumulating drug delivery vehicles for the treatment of liver diseases. Zhang G; Huang X; Xiu H; Sun Y; Chen J; Cheng G; Song Z; Peng Y; Shen Y; Wang J; Cai Z J Extracell Vesicles; 2020 Dec; 10(2):e12030. PubMed ID: 33335695 [TBL] [Abstract][Full Text] [Related]
10. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. O'Brien KP; Khan S; Gilligan KE; Zafar H; Lalor P; Glynn C; O'Flatharta C; Ingoldsby H; Dockery P; De Bhulbh A; Schweber JR; St John K; Leahy M; Murphy JM; Gallagher WM; O'Brien T; Kerin MJ; Dwyer RM Oncogene; 2018 Apr; 37(16):2137-2149. PubMed ID: 29367765 [TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610 [TBL] [Abstract][Full Text] [Related]
12. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168 [TBL] [Abstract][Full Text] [Related]
13. Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis. Samuel M; Fonseka P; Sanwlani R; Gangoda L; Chee SH; Keerthikumar S; Spurling A; Chitti SV; Zanker D; Ang CS; Atukorala I; Kang T; Shahi S; Marzan AL; Nedeva C; Vennin C; Lucas MC; Cheng L; Herrmann D; Pathan M; Chisanga D; Warren SC; Zhao K; Abraham N; Anand S; Boukouris S; Adda CG; Jiang L; Shekhar TM; Baschuk N; Hawkins CJ; Johnston AJ; Orian JM; Hoogenraad NJ; Poon IK; Hill AF; Jois M; Timpson P; Parker BS; Mathivanan S Nat Commun; 2021 Jun; 12(1):3950. PubMed ID: 34168137 [TBL] [Abstract][Full Text] [Related]
14. Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors. Villa A; Crescenti D; De Mitri Z; Crippa E; Rosa S; Rizzi N; Shojaei-Ghahrizjani F; Rebecchi M; Vincenti S; Selmin F; Brunialti E; Simonotti N; Maspero M; Dei Cas M; Recordati C; Paltrinieri S; Giordano A; Paroni R; Galassi M; Ladisa V; Arienti F; Cilurzo F; Mazzaferro V; Ciana P Theranostics; 2024; 14(16):6301-6318. PubMed ID: 39431003 [TBL] [Abstract][Full Text] [Related]
15. IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles. Kuhn M; Zhang Y; Favate J; Morita M; Blucher A; Das S; Liang S; Preet R; Parham LR; Williams KN; Molugu S; Armstrong RJ; Zhang W; Yang J; Hamilton KE; Dixon DA; Mills G; Morgan TK; Shah P; Andres SF Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G571-G585. PubMed ID: 36194131 [TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy. Zhuang J; Tan J; Wu C; Zhang J; Liu T; Fan C; Li J; Zhang Y Nucleic Acids Res; 2020 Sep; 48(16):8870-8882. PubMed ID: 32810272 [TBL] [Abstract][Full Text] [Related]
17. Silencing microRNA-210 in Hypoxia-Induced HUVEC-Derived Extracellular Vesicles Inhibits Hemangioma. Ma J; Tao X; Huang Y Cerebrovasc Dis; 2020; 49(5):462-473. PubMed ID: 32877893 [TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells. Endzeliņš E; Ābols A; Bušs A; Zandberga E; Palviainen M; Siljander P; Linē A Anticancer Res; 2018 Sep; 38(9):5139-5147. PubMed ID: 30194161 [TBL] [Abstract][Full Text] [Related]
19. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker. Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming. Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]